ORIC Oric Pharmaceuticals, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 5, 2026 10-K/10-Q Aug 3, 2026
$12,16
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$7,2352-Wochen-Tief
$14,9352-Wochen-Hoch
Marktkapitalisierung (MRQ)
$1.26B
P/E
-8.7
EPS
$-1.47
Ihre Abzeichen
52W-Spanne
$7–$15
Analystenbewertung
BUY
Kursziel
$21
P/E
-8.7
ROE
-36.5%
Nettogewinnmarge
·
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
ORIC Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$12.15
Marktkapitalisierung (MRQ)
$1.26B
P/E
-8.7
EPS
$-1.47
ROE
-36.5%
52W-Spanne
$7–$15
ORIC Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
EPS$-1.472021-12-31 → 2025-12-31
Freier Cashflow$-112M2020-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | ORIC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -8.75-Jahres-Durchschnitt ≈-4.9 | ≈-4.9 | · | · | |
| K/B (MRQ) | 3.35-Jahres-Durchschnitt ≈2.0 | ≈2.0 | 4.2 | Unterbewertet | |
| Kurs / FCF (TTM) | -11.25-Jahres-Durchschnitt ≈-6.2 | ≈-6.2 | · | · | |
| Kurs / Cashflow (TTM) | -11.35-Jahres-Durchschnitt ≈-6.3 | ≈-6.3 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 3.35-Jahres-Durchschnitt ≈2.0 | ≈2.0 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | ORIC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| ROA | -37.9%5-Jahres-Durchschnitt ≈-37.2% | ≈-37.2% | -37.9% | Im Einklang | |
| ROE | -36.5%5-Jahres-Durchschnitt ≈-39.5% | ≈-39.5% | -59.7% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | ORIC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 13.25-Jahres-Durchschnitt ≈12.9 | ≈12.9 | 11.6 | Im Einklang | |
| Quick Ratio | 2.25-Jahres-Durchschnitt ≈5.0 | ≈5.0 | 11.0 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
8.2%
Nächster Bericht
Nov 11, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 10, 2026 | $-0.38 | $-0.37 | -3.1% |
| 31. März 2026 | $-0.34 | $-0.33 | -2.7% | |
| 31. Dezember 2025 | $-0.30 | $-0.37 | 19.2% | |
| 30. September 2025 | $-0.33 | $-0.41 | 20.1% | |
| 30. Juni 2025 | $-0.47 | $-0.45 | -4.0% | |
| 31. März 2025 | $-0.42 | $-0.52 | 19.4% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| SG&A Expense | $33M | $29M | $26M | $25M | $22M | $13M | $6M | |
| Operating Expenses | $143M | $143M | $111M | $92M | $79M | $74M | $29M | |
| Operating Income | $-143M | $-143M | $-111M | $-92M | $-79M | $-74M | $-29M | |
| Other Non-op | $14M | $15M | $10M | $3M | $156.0K | $483.0K | $2M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-129M | $-128M | $-101M | $-89M | $-79M | $-74M | $-27M | |
| EPS (Basic) | $-1.47 | $-1.83 | $-1.96 | $-2.25 | $-2.07 | · | · | |
| EPS (Diluted) | $-1.47 | $-1.83 | $-1.96 | $-2.25 | $-2.07 | · | · | |
| Shares (Basic) | 87,793,801 | 69,727,940 | 51,450,848 | 39,655,260 | 37,954,280 | · | · | |
| Shares (Diluted) | 87,793,801 | 69,727,940 | 51,450,848 | 39,655,260 | 37,954,280 | · | · | |
| EBITDA | $-143M | $-143M | $-111M | $-92M | $-79M | $-74M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $46M | $59M | $23M | $67M | $226M | $78M | $89M | |
| Short-term Investments | · | · | · | · | · | $215M | · | |
| Prepaid Expense | $7M | $6M | $4M | $4M | $4M | $3M | $840.0K | |
| Current Assets | $288M | $262M | $213M | $210M | $241M | $297M | $90M | |
| PP&E (Net) | $2M | $3M | $3M | $3M | $2M | $2M | $2M | |
| PP&E (Gross) | $10M | $10M | $9M | $9M | $7M | $6M | $6M | |
| Accum. Depreciation | $8M | $7M | $6M | $6M | $5M | $4M | $4M | |
| Other Non-current Assets | $7M | $9M | $10M | $12M | $12M | $319.0K | $2M | |
| Total Assets | $409M | $274M | $252M | $247M | $299M | $299M | $94M | |
| Accounts Payable | $4M | $2M | $944.0K | $1M | $2M | $757.0K | $152.0K | |
| Accrued Liabilities | $17M | $23M | $20M | $14M | $13M | $8M | $5M | |
| Current Liabilities | $20M | $25M | $20M | $15M | $15M | $9M | $5M | |
| Capital Leases | $4M | $6M | $7M | $9M | $10M | · | · | |
| Other Non-current Liabilities | $4M | $6M | $7M | $9M | $11M | $219.0K | · | |
| Total Liabilities | $25M | $31M | $28M | $25M | $26M | $9M | $6M | |
| Long-term Debt | · | · | · | · | $10M | · | · | |
| Common Stock | $11.0K | $7.0K | $6.0K | $5.0K | $4.0K | $4.0K | · | |
| Retained Earnings | $-692M | $-563M | $-435M | $-334M | $-245M | $-166M | $-93M | |
| AOCI | $786.0K | $379.0K | $258.0K | $-1M | $-103.0K | $-31.0K | · | |
| Stockholders' Equity | $384M | $243M | $224M | $222M | $273M | $290M | $-90M | |
| Liabilities + Equity | $409M | $274M | $252M | $247M | $299M | $299M | $94M | |
| Shares Outstanding | 98,528,949 | 71,021,855 | 54,865,553 | 45,089,537 | 39,430,120 | 36,672,415 | 1,984,222 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $25M | $20M | $15M | $14M | $13M | $5M | $1M | |
| Operating Cash Flow | $-111M | $-113M | $-86M | $-75M | $-60M | $-45M | $-24M | |
| CapEx | $712.0K | $1M | $849.0K | $2M | $939.0K | $667.0K | $768.0K | |
| Investing Cash Flow | $-148M | $22M | $-43M | $-109M | $158M | $-216M | $-768.0K | |
| Stock Issued | $244M | $125M | $85M | $25M | $50M | $271M | · | |
| Net Stock Activity | $244M | $125M | $85M | $25M | $50M | $133M | · | |
| Financing Cash Flow | $245M | $127M | $86M | $25M | $49M | $251M | $71M | |
| Net Change in Cash | $-14M | $36M | $-43M | $-159M | $148M | $-11M | $47M | |
| Free Cash Flow | $-112M | $-114M | $-87M | $-77M | $-60M | $-46M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| ROA | -37.9% | -48.6% | -40.3% | -32.7% | -26.3% | -37.5% | · | |
| ROE | -36.5% | -49.5% | -42.7% | -40.8% | -27.9% | -31.1% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 14.1 | 10.6 | 10.4 | 13.7 | 15.9 | 33.0 | · | |
| Quick Ratio | 2.2 | 2.4 | 1.1 | 4.3 | 14.9 | 32.6 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.90 | $3.42 | $4.08 | $4.93 | $6.92 | $7.90 | · | |
| Cash Flow / Share | $-1.26 | $-1.62 | $-1.67 | $-1.89 | · | · | · | |
| Cash / Share | $0.46 | $0.84 | $0.43 | $1.48 | $5.73 | $2.14 | · | |
| EPS (TTM) | $-1.47 | $-1.83 | $-1.96 | $-2.25 | $-2.07 | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-129M | $-128M | $-101M | $-89M | $-79M | $-74M | · | |
| Market Cap | $806M | $573M | $505M | $266M | $580M | $1.24B | · | |
| P/E | -5.6 | -4.4 | -4.7 | -2.6 | -7.1 | · | · | |
| P/B | 2.1 | 2.4 | 2.3 | 1.2 | 2.1 | 4.3 | · | |
| P / Tangible Book | 2.1 | 2.4 | 2.3 | 1.2 | 2.1 | 4.3 | · | |
| P / Cash Flow | -7.3 | -5.1 | -5.9 | -3.5 | -9.7 | -27.4 | · | |
| P / FCF | -7.2 | -5.0 | -5.8 | -3.4 | -9.6 | -27.0 | · | |
| Earnings Yield | -18.0% | -22.7% | -21.3% | -38.2% | -14.1% | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SG&A Expense | $9M | $8M | $9M | $8M | $9M | $8M | $8M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | |
| Operating Expenses | $45M | $40M | $35M | $37M | $39M | $33M | $40M | $38M | $36M | $29M | $31M | $29M | $25M | $26M | $22M | $26M | |
| Operating Income | $-45M | $-40M | $-35M | $-37M | $-39M | $-33M | $-40M | $-38M | $-36M | $-29M | $-31M | $-29M | $-25M | $-26M | $-22M | $-26M | |
| Other Non-op | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $4M | $4M | $4M | $3M | $3M | $2M | $2M | $1M | $865.0K | |
| Net Income | $-41M | $-36M | $-31M | $-33M | $-36M | $-30M | $-36M | $-35M | $-32M | $-25M | $-28M | $-25M | $-23M | $-24M | $-21M | $-25M | |
| EPS (Basic) | $-0.38 | $-0.34 | $-0.25 | $-0.33 | $-0.47 | $-0.42 | $-0.52 | $-0.49 | $-0.45 | $-0.37 | $-0.49 | $-0.44 | $-0.50 | $-0.53 | $-0.52 | $-0.63 | |
| EPS (Diluted) | $-0.38 | $-0.34 | $-0.25 | $-0.33 | $-0.47 | $-0.42 | $-0.52 | $-0.49 | $-0.45 | $-0.37 | $-0.49 | $-0.44 | $-0.50 | $-0.53 | $-0.52 | $-0.63 | |
| Shares (Basic) | 108,012,388 | 105,472,766 | · | 98,953,331 | 78,126,257 | 71,040,580 | · | 70,542,684 | 70,348,414 | 67,349,551 | · | 57,402,226 | 45,654,208 | 45,090,166 | · | 39,575,660 | |
| Shares (Diluted) | 108,012,388 | 105,472,766 | · | 98,953,331 | 78,126,257 | 71,040,580 | · | 70,542,684 | 70,348,414 | 67,349,551 | · | 57,402,226 | 45,654,208 | 45,090,166 | · | 39,575,660 | |
| EBITDA | $-45M | $-40M | · | $-37M | $-39M | $-33M | · | $-38M | $-36M | $-29M | · | $-29M | $-25M | $-26M | · | $-26M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $37M | $56M | $46M | $50M | $76M | $49M | $59M | $44M | $50M | $56M | $23M | $26M | $104M | $59M | $67M | $29M | |
| Prepaid Expense | $9M | $8M | $7M | $8M | $9M | $8M | $6M | $7M | $8M | $7M | $4M | $5M | $4M | $4M | $4M | $5M | |
| Current Assets | $274M | $290M | $288M | $296M | $291M | $211M | $262M | $279M | $295M | $324M | $213M | $232M | $268M | $193M | $210M | $199M | |
| PP&E (Net) | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| PP&E (Gross) | $10M | $10M | $10M | $11M | $11M | $11M | $10M | $10M | $10M | $9M | $9M | $10M | $10M | $9M | $9M | $9M | |
| Accum. Depreciation | $8M | $8M | $8M | $8M | $8M | $8M | $7M | $7M | $7M | $7M | $6M | $7M | $6M | $6M | $6M | $6M | |
| Other Non-current Assets | $6M | $7M | $7M | $7M | $8M | $8M | $9M | $10M | $9M | $9M | $10M | $10M | $11M | $11M | $12M | $12M | |
| Total Assets | $405M | $437M | $409M | $431M | $347M | $243M | $274M | $302M | $329M | $351M | $252M | $274M | $292M | $227M | $247M | $238M | |
| Accounts Payable | $4M | $3M | $4M | $3M | $3M | $5M | $2M | $4M | $2M | $3M | $944.0K | $4M | $3M | $2M | $1M | $2M | |
| Accrued Liabilities | $17M | $15M | $17M | $17M | $15M | $12M | $23M | $17M | $17M | $12M | $20M | $15M | $11M | $13M | $14M | $12M | |
| Current Liabilities | $21M | $18M | $20M | $20M | $18M | $18M | $25M | $21M | $20M | $15M | $20M | $19M | $15M | $15M | $15M | $13M | |
| Capital Leases | · | · | $4M | · | · | · | $6M | · | · | · | $7M | · | · | · | $9M | · | |
| Other Non-current Liabilities | $3M | $3M | $4M | $4M | $5M | $6M | $6M | $7M | $7M | $7M | $7M | $8M | $8M | $9M | $9M | $10M | |
| Total Liabilities | $23M | $21M | $25M | $24M | $23M | $23M | $31M | $28M | $27M | $22M | $28M | $27M | $23M | $24M | $25M | $23M | |
| Common Stock | $11.0K | $11.0K | $11.0K | $11.0K | $9.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $4.0K | |
| Retained Earnings | $-770M | $-728M | $-692M | $-662M | $-629M | $-593M | $-563M | $-526M | $-492M | $-460M | $-435M | $-407M | $-381M | $-358M | $-334M | $-313M | |
| AOCI | $-1M | $-290.0K | $786.0K | $615.0K | $187.0K | $209.0K | $379.0K | $722.0K | $-256.0K | $-162.0K | $258.0K | $-369.0K | $-567.0K | $-499.0K | $-1M | $-2M | |
| Stockholders' Equity | $381M | $416M | $384M | $407M | $324M | $220M | $243M | $274M | $302M | $329M | $224M | $247M | $269M | $203M | $222M | $215M | |
| Liabilities + Equity | $405M | $437M | $409M | $431M | $347M | $243M | $274M | $302M | $329M | $351M | $252M | $274M | $292M | $227M | $247M | $238M | |
| Shares Outstanding | 103,636,424 | 103,486,412 | 98,528,949 | 97,278,032 | 86,187,328 | 71,078,511 | 71,021,855 | 70,559,183 | 67,672,303 | 67,420,338 | 54,865,553 | 54,540,715 | 54,532,171 | 45,091,215 | 45,089,537 | 39,576,047 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $7M | $7M | $6M | $6M | $7M | $7M | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $3M | $3M | |
| Operating Cash Flow | $-32M | $-32M | $-22M | $-25M | $-31M | $-33M | $-28M | $-29M | $-26M | $-30M | $-24M | $-20M | $-21M | $-21M | $-15M | $-19M | |
| CapEx | $356.0K | $2.0K | $227.0K | $35.0K | $63.0K | $387.0K | $219.0K | $418.0K | $333.0K | $218.0K | $57.0K | $77.0K | $405.0K | $310.0K | $287.0K | $401.0K | |
| Investing Cash Flow | $12M | $-18M | $17M | $-111M | $-77M | $22M | $43M | $23M | $18M | $-62M | $21M | $-58M | $-19M | $13M | $28M | $-685.0K | |
| Stock Issued | $0 | $61M | $0 | $110M | $134M | $0 | $0 | $0 | $0 | $125M | $0 | $226.0K | $85M | $0 | $25M | $-354.0K | |
| Net Stock Activity | · | $61M | · | · | · | $0 | · | · | · | $125M | · | · | · | · | · | · | |
| Financing Cash Flow | $828.0K | $61M | $2M | $109M | $134M | $11.0K | $575.0K | $126.0K | $816.0K | $125M | $453.0K | $31.0K | $85M | $0 | $25M | $1.0K | |
| Net Change in Cash | $-19M | $11M | $-4M | $-26M | $27M | $-10M | $15M | $-6M | $-7M | $33M | $-3M | $-77M | $45M | $-8M | $38M | $-20M | |
| Free Cash Flow | · | $-32M | · | · | · | $-33M | · | · | · | $-30M | · | · | · | $-21M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -11.0% | -10.5% | · | -8.9% | -10.8% | -10.1% | · | -12.0% | -10.3% | -8.7% | · | -10.0% | -8.3% | -9.6% | · | -9.0% | |
| ROE | -11.8% | -11.3% | · | -9.6% | -11.6% | -10.9% | · | -13.3% | -11.2% | -9.4% | · | -11.0% | -9.1% | -10.5% | · | -9.8% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 13.2 | 16.3 | · | 14.6 | 16.1 | 12.0 | · | 13.2 | 15.1 | 21.3 | · | 12.3 | 18.5 | 13.0 | · | 15.0 | |
| Quick Ratio | 1.8 | 3.2 | · | 2.5 | 4.2 | 2.8 | · | 2.1 | 2.6 | 3.7 | · | 1.4 | 7.1 | 4.0 | · | 2.2 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.68 | $4.02 | · | $4.18 | $3.76 | $3.09 | · | $3.88 | $4.47 | $4.87 | · | $4.54 | $4.93 | $4.50 | · | $5.43 | |
| Cash Flow / Share | · | $-0.31 | · | · | · | $-0.46 | · | · | · | $-0.45 | · | · | · | $-0.46 | · | · | |
| Cash / Share | $0.36 | $0.55 | · | $0.51 | $0.88 | $0.69 | · | $0.63 | $0.74 | $0.84 | · | $0.48 | $1.90 | $1.31 | · | $0.73 | |
| EPS (TTM) | $-1.30 | $-1.39 | · | $-1.74 | $-1.90 | $-1.88 | · | $-1.80 | $-1.75 | $-1.80 | · | $-1.99 | $-2.18 | $-2.19 | · | $-2.31 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-140M | $-135M | · | $-135M | $-137M | $-133M | · | $-120M | $-111M | $-102M | · | $-93M | $-93M | $-90M | · | $-91M | |
| Market Cap | $1.12B | $1.31B | · | $1.17B | $875M | $397M | · | $723M | $478M | $927M | · | $330M | $423M | $257M | · | $127M | |
| P/E | -8.3 | -9.1 | · | -6.9 | -5.3 | -3.0 | · | -5.7 | -4.0 | -7.6 | · | -3.0 | -3.6 | -2.6 | · | -1.4 | |
| P/B | 2.9 | 3.2 | · | 2.9 | 2.7 | 1.8 | · | 2.6 | 1.6 | 2.8 | · | 1.3 | 1.6 | 1.3 | · | 0.6 | |
| P / Tangible Book | 2.9 | 3.2 | · | 2.9 | 2.7 | 1.8 | · | 2.6 | 1.6 | 2.8 | · | 1.3 | 1.6 | 1.3 | · | 0.6 | |
| P / Cash Flow | · | -40.4 | · | · | · | -12.2 | · | · | · | -30.7 | · | · | · | -12.5 | · | · | |
| Earnings Yield | -12.0% | -11.0% | · | -14.5% | -18.7% | -33.7% | · | -17.6% | -24.8% | -13.1% | · | -32.9% | -28.1% | -38.4% | · | -72.2% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Nettoergebnis | $-129M | $-128M | $-101M | $-89M | $-79M |
| Verwässerte EPS | $-1.47 | $-1.83 | $-1.96 | $-2.25 | $-2.07 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 14.1 | 10.6 | 10.4 | 13.7 | 15.9 |
| Quick Ratio | 2.2 | 2.4 | 1.1 | 4.3 | 14.9 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-112M | $-114M | $-87M | $-77M | $-60M |
Institutionelle Eigentümer (13F) 188 Einreicher · $1.3B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
188
Gehaltener Wert
$1.3B
Neue Positionen
32
Geschlossene Positionen
29
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 32 (-11 vs. Vorquartal) | 29 (+11 vs. Vorquartal) | 81 (+27 vs. Vorquartal) | 41 (-22 vs. Vorquartal) | +4.7M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Nextech Invest Ltd. | $77.571.359 | 7.162.637 | 5,94% | Aktien |
| BlackRock, Inc. | $73.903.628 | 6.823.973 | 5,66% | Aktien |
| EcoR1 Capital, LLC | $72.865.496 | 6.728.116 | 5,58% | Aktien |
| VIKING GLOBAL INVESTORS LP | $55.522.832 | 5.126.762 | 4,25% | Aktien |
| STATE STREET CORP | $53.002.020 | 4.894.000 | 4,06% | Aktien |
| SR One Capital Management, LP | $49.984.609 | 4.615.384 | 3,83% | Aktien |
| Venrock Adviser, LLC | $46.783.055 | 4.319.765 | 3,58% | Aktien |
| NEA Management Company, LLC | $44.604.665 | 4.118.621 | 3,42% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $42.791.160 | 3.951.169 | 3,28% | Aktien |
| AIHC Capital Management Ltd | $41.462.222 | 3.828.460 | 3,18% | Aktien |
| ALKEON CAPITAL MANAGEMENT LLC | $40.494.410 | 3.739.096 | 3,10% | Aktien |
| Column Group LLC | $38.346.615 | 3.540.777 | 2,94% | Aktien |
| VANGUARD GROUP INC | $37.153.347 | 4.541.974 | 2,85% | Aktien |
| Siren, L.L.C. | $32.470.419 | 2.998.192 | 2,49% | Aktien |
| FMR LLC | $28.542.194 | 2.635.475 | 2,19% | Aktien |
| CITADEL ADVISORS LLC | $28.107.088 | 2.595.299 | 2,15% | Aktien |
| GOLDMAN SACHS GROUP INC | $26.552.951 | 2.451.796 | 2,03% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $22.639.952 | 2.090.089 | 1,73% | Aktien |
| First Turn Management, LLC | $21.847.186 | 2.017.284 | 1,67% | Aktien |
| ORBIMED ADVISORS LLC | $21.822.450 | 2.015.000 | 1,67% | Aktien |
| Integral Health Asset Management, LLC | $20.577.000 | 1.900.000 | 1,58% | Aktien |
| MPM BIOIMPACT LLC | $20.383.814 | 1.882.162 | 1,56% | Aktien |
| Vivo Capital, LLC | $20.022.352 | 1.848.786 | 1,53% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $19.503.242 | 1.801.399 | 1,49% | Aktien |
| FRANKLIN RESOURCES INC | $19.465.593 | 1.797.377 | 1,49% | Aktien |
| MORGAN STANLEY | $19.429.237 | 1.794.020 | 1,49% | Aktien |
| D. E. Shaw & Co., Inc. | $17.113.739 | 1.580.216 | 1,31% | Aktien |
| Woodline Partners LP | $13.510.587 | 1.247.515 | 1,03% | Aktien |
| ALGERT GLOBAL LLC | $13.161.623 | 1.215.293 | 1,01% | Aktien |
| BRAIDWELL LP | $13.153.468 | 1.214.540 | 1,01% | Aktien |
| Candriam S.C.A. | $12.764.594 | 1.179.768 | 0,98% | Aktien |
| BANK OF AMERICA CORP /DE/ | $11.675.336 | 1.078.055 | 0,89% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $11.392.109 | 1.051.903 | 0,87% | Aktien |
| Defilade Capital Management, L.P. | $11.346.483 | 1.047.690 | 0,87% | Aktien |
| Euclidean Capital LLC | $10.715.310 | 989.410 | 0,82% | Aktien |
| ROYCE & ASSOCIATES LP | $10.609.761 | 979.664 | 0,81% | Aktien |
| EVENTIDE ASSET MANAGEMENT, LLC | $10.337.886 | 954.768 | 0,79% | Aktien |
| NORTHERN TRUST CORP | $8.732.272 | 806.304 | 0,67% | Aktien |
| Qube Research & Technologies Ltd | $8.604.890 | 794.542 | 0,66% | Aktien |
| SPHERA FUNDS MANAGEMENT LTD. | $8.154.806 | 752.983 | 0,62% | Aktien |
| Jones Hill Capital LP | $8.093.400 | 747.313 | 0,62% | Aktien |
| SILVERARC CAPITAL MANAGEMENT, LLC | $8.001.995 | 738.873 | 0,61% | Aktien |
| NEXTBio Capital Management LP | $7.647.323 | 706.124 | 0,59% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $7.556.026 | 697.694 | 0,58% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $7.340.823 | 677.823 | 0,56% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $6.808.626 | 628.682 | 0,52% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $6.537.681 | 603.664 | 0,50% | Aktien |
| ArrowMark Colorado Holdings LLC | $6.312.536 | 582.875 | 0,48% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $6.130.192 | 566.038 | 0,47% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $5.614.922 | 518.460 | 0,43% | Aktien |
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| SR One Capital Management, LLC, SR One Capital Opportunities Fund I, LP, SR One Capital Opportunities Partners I, LP, AMZL, LP, SR One Capital SMA Partners, LP, SR One Capital Fund II Aggregator, LP, SR One Capital Partners II, LP, Simeon George ×2 Einreichungen | 14. August 2025 | 4,75% | Änderung | · | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP VI LLC, OrbiMed Capital LLC ×5 Einreichungen | 27. Dezember 2022 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 11 Insider · 3 Führungskräfte · 9 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jacob Chacko | PRESIDENT AND CEO | 2. Januar 2026 A | 581.711 | 0 | 2 | $-763.888 |
| Dominic Piscitelli | Chief Financial Officer | 28. September 2026 M | 69.828 | 0 | 7 | $-2.202.895 |
| Pratik S Multani | Chief Medical Officer | 2. Januar 2026 A | 68.149 | 0 | 1 | $-97.123 |
| Richard A. Heyman | Direktor | 1. Oktober 2026 M | 203.472 | 0 | 7 | $-327.959 |
| Angie You | Direktor | 2. Januar 2026 A | 28.000 | 0 | 0 | $0 |
| Mardi Dier | Direktor | 2. Januar 2026 A | · | 0 | 0 | $0 |
| Lori Anne Kunkel | Direktor | 2. Januar 2026 A | 84.200 | 0 | 0 | $0 |
| Steven L. Hoerter | Direktor | 2. Januar 2026 A | · | 0 | 0 | $0 |
| Peter Svennilson | Direktor | 16. Juni 2021 A | 4.768.181 | 0 | 0 | $0 |
| GORDON CARL L | Direktor | 16. Juni 2021 A | 2.212.571 | 0 | 0 | $0 |
| Richard H Scheller | Direktor | 24. Mai 2021 S | 39.092 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 33 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,90% | 37.585 NS | 31. Juli 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,25% | 110.953 NS | 31. Juli 2026 | N-PORT |
| IWC · iShares Trust | 0,21% | 254.020 SH | 11. September 2026 | Täglich |
| ESSC · Strategy Shares | 0,13% | 4.173 NS | 31. Juli 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,09% | 7.315 SH | 2. Oktober 2026 | Täglich |
| PWS · Pacer Funds Trust | 0,07% | 1.516 NS | 31. Juli 2026 | N-PORT |
| IBB · iShares Trust | 0,05% | 468.238 SH | 11. September 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,04% | 44.861 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,03% | 1.911.685 SH | 11. September 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 61.621 SH | 2. Oktober 2026 | Täglich |
| RSSL · Global X Funds | 0,03% | 35.677 NS | 31. Juli 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,02% | 334.199 NS | 31. Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 429.878 SH | 19. August 2026 | Täglich |
| IWO · iShares Trust | 0,02% | 214.505 SH | 11. September 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 942.459 SH | 19. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 23.339 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 125.232 SH | 19. August 2026 | Täglich |
| ISCG · iShares Trust | 0,01% | 7.518 SH | 11. September 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 20.639 NS | 31. Juli 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,01% | 3.366 NS | 31. Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,00% | 2.678 SH | 11. September 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,00% | 198.641 NS | 31. Juli 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 7.742 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 9.920 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 22.716 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 116.405 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 17.689 SH | 3. September 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,00% | 11.672 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.918.973 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 5.372 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 480.334 SH | 11. September 2026 | Täglich |
| ISCB · iShares Trust | · | 2.918 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 9.176 SH | 11. September 2026 | Täglich |
ORIC Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 20 Analysten
KAUF
Median-Ziel
$22.00
+81,0%
8 40,0%
Starker Kauf
10 50,0%
Kauf
2 10,0%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
13 Analysten · 2026-09-30Mittelwert-Ziel $21.08 +73,4%
← Unter allen Zielen
Aktueller Preis $12.15
Tief$14.00
Mittelwert$21.08
Hoch$27.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ORIC | $806M | -5.6 | · | · | -36.5% | · |
| INBX | $1.15B | -8.7 | 550.0% | -10773.5% | -365.9% | · |
| TYRA | $1.41B | -13.1 | · | · | -42.7% | · |
| AVBP | $854M | -4.7 | · | · | -59.7% | · |
| KLRA | · | · | · | · | · | · |
| DMRA | · | · | 38.3% | -17981.1% | -167.0% | · |
| REPL | $633M | -2.3 | · | · | -146.2% | · |
| MNKD | $1.75B | 283.5 | 22.2% | 1.7% | -11.1% | · |
| TRAX | · | · | · | · | · | · |
| BCAX | $953M | -6.7 | · | · | -33.0% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 3, 2026